Biotech - Curation

Insights on AI & drug discovery, genetics, computational biology & the future of medicine!
Not investment advice, disclaimers on our website.

[Biotech - Curation @BiotechCuration]

A great post by @glyn_dk on evaluating strategies in drug discovery programs.https://t.co/v10Baoxr22
The market is big, but without efficiency, it hasn't made sense. $ETX brings that efficiency.
https://t.co/uy7HLXnHsy

[Biotech - Curation @BiotechCuration]

https://t.co/xZZ5OgHLmw
Could $VKTX be ripe for consolidation? Interesting thoughts? Who else could be of interest? #AI drug discovery is the hot topic - $ATX @curationconnec

[Biotech - Curation @BiotechCuration]

What a day for $VKTX - more than loss weight drugs are being developed utilizing #AI for drug discovery - learn more @curationconnect

$ATX https://t.co/uy7HLXnHsy

[Biotech - Curation @BiotechCuration]

https://t.co/3hoGjzuVxv
@FT highlighting investment in AI-driven drug discovery companies. Don't forget $ETX and learn more https://t.co/uy7HLXnHsy

[Biotech - Curation @BiotechCuration]

https://t.co/zGM4qBsSfQ
@financialtimes has recently looked at what AI might do to accelerate drug discovery, cancer diagnosis, and more fundamental genetic research. This sounds like the e-Therapeutics playbook... https://t.co/uy7HLXnHsy

[Biotech - Curation @BiotechCuration]

How do you bring expensive drugs to market at a more affordable price for those who are in desperate need? @e_therapeutics uses #AI at every stage of #drugdiscovery and #drugdevelopment to massively reduce costs >> https://t.co/ZNeZpVigXw

[Reuters Health @Reuters_Health]

Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022, reflecting in part the industry's embrace of expensive therapies for rare diseases like muscular dystrophy, a Reuters analysis found. https://t.co/9VVBiOhUt1 https://t.co/9VVBiOhUt1

[Biotech - Curation @BiotechCuration]

It's all about Nvidia and AI. What companies are utilizing AI in their workflow within the drug discovery space? e-Therapeutics embraces AI and the power it brings: https://t.co/tpTMk4YoYZ

https://t.co/uy7HLXnHsy

[Biotech - Curation @BiotechCuration]

Weight Loss Drugs vs Food! Eating habits are evolving as these drugs become ever-popular. Where do these drugs come from, and how do they evolve? https://t.co/W8StmcFN08

e-therapeutics at the forefront of identifying gene-disease targets and therapies - https://t.co/uy7HLXnHsy

[Biotech - Curation @BiotechCuration]

Is it really possible to "Compute the Future of Medicine?" $ETX @e_therapeutics #drugdiscovery #ai #computationalbiology #techbio #biotech learn more >> https://t.co/uy7HLXnHsy

[Biotech - Curation @BiotechCuration]

@AAMortazavi Learn what this might mean for @e_therapeutics by diving into it's investment showcase $ETX https://t.co/BLntsIRO9M

[Biotech - Curation @BiotechCuration]

@AAMortazavi 's (now CEO $ETX) previous RNAi biotech $SLN just raised an oversubscribed round at 11% premium

[Bio Stocks™ @BioStocks]

$SLN Announces Oversubscribed $120M Private Placement.
5.71M ADS at $21/ADS.

Investors include Logos Capital, 5AM Ventures, Frazier Life Sciences, Nextech Invest, Redmile Group, TCGX and Vivo Capital.

[Biotech - Curation @BiotechCuration]

Computing the future of medicine! Check out @e_therapeutics investment showcase for everything you need to know about the company $ETX https://t.co/BLntsIRO9M

[Biotech - Curation @BiotechCuration]

Our mission is to compliantly inform and educate by ensuring all investors have equal access to information. Go to https://t.co/4zAMf0khmK to learn more or follow @curationconnect.